Shares of Sun Pharmaceutical Industries experienced a downturn during today's trading session, with the stock price decreasing by 0.51% to Rs 1722.90. This movement reflects notable market activity for the pharmaceutical giant, which is a constituent of the NIFTY 50 STOCKS.
Financial Performance
Sun Pharmaceutical Industries has demonstrated consistent financial performance over the past several quarters. Analysing the company's revenue, net profit, and EPS trends provides insight into its stability and growth.
Quarterly Results:
The following table summarizes the consolidated quarterly financial results:
| Quarter | Revenue (Cr) | Net Profit (Cr) | EPS |
|---|---|---|---|
| Dec 2023 | Rs 12,380.70 | Rs 2,568.03 | 10.50 |
| Mar 2024 | Rs 11,982.90 | Rs 2,666.59 | 11.10 |
| Jun 2024 | Rs 12,652.75 | Rs 2,871.25 | 11.80 |
| Sep 2024 | Rs 13,291.39 | Rs 3,030.67 | 12.70 |
| Dec 2024 | Rs 13,675.46 | Rs 2,917.54 | 12.10 |
The yearly financial data provides a broader perspective on Sun Pharmaceutical Industries' financial health. Key metrics include revenue, net profit, EPS, BVPS, ROE, and Debt to Equity ratio.
| Year | Revenue (Cr) | Net Profit (Cr) | EPS | BVPS | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| 2020 | Rs 32,837.50 | Rs 4,186.79 | 15.70 | 204.75 | 8.31 | 0.17 |
| 2021 | Rs 33,498.14 | Rs 2,284.68 | 12.10 | 206.23 | 6.24 | 0.07 |
| 2022 | Rs 38,654.49 | Rs 3,405.82 | 13.60 | 212.84 | 6.81 | 0.02 |
| 2023 | Rs 43,885.68 | Rs 8,560.84 | 35.30 | 247.22 | 15.13 | 0.11 |
| 2024 | Rs 48,496.85 | Rs 9,648.44 | 39.90 | 279.69 | 15.04 | 0.04 |
Sun Pharmaceutical Industries' performance in today's session reflects notable market activity for the pharmaceutical giant.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
